The Food And Drug Administration issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.
The use of the drug - often paired with azithromycin - has not yet been proven in clinical trials to be effective against the disease.
Given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the "Off-label" drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill.
The U.S. Food and Drug Administration issued an Emergency Use Authorization to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.
Earlier, the French government had approved similar drugs to treat the virus.
Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: "Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis."
His interest in the drug has prompted pushback from the media.
https://www.breitbart.com/health/2020/03/29/fda-gives-emergency-authorization-of-hydroxychloroquine-use/
The use of the drug - often paired with azithromycin - has not yet been proven in clinical trials to be effective against the disease.
Given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the "Off-label" drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill.
The U.S. Food and Drug Administration issued an Emergency Use Authorization to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.
Earlier, the French government had approved similar drugs to treat the virus.
Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: "Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis."
His interest in the drug has prompted pushback from the media.
https://www.breitbart.com/health/2020/03/29/fda-gives-emergency-authorization-of-hydroxychloroquine-use/
No comments:
Post a Comment